Joakim Riikonen
Title
Cited by
Cited by
Year
Mesoporous systems for poorly soluble drugs
W Xu, J Riikonen, VP Lehto
International journal of pharmaceutics 453 (1), 181-197, 2013
2152013
In vitro cytotoxicity of porous silicon microparticles: effect of the particle concentration, surface chemistry and size
HA Santos, J Riikonen, J Salonen, E Mäkilä, T Heikkilä, T Laaksonen, ...
Acta biomaterialia 6 (7), 2721-2731, 2010
1782010
Failure of MTT as a toxicity testing agent for mesoporous silicon microparticles
T Laaksonen, H Santos, H Vihola, J Salonen, J Riikonen, T Heikkilä, ...
Chemical research in toxicology 20 (12), 1913-1918, 2007
1622007
In vivo delivery of a peptide, ghrelin antagonist, with mesoporous silicon microparticles
M Kilpeläinen, J Riikonen, MA Vlasova, A Huotari, VP Lehto, J Salonen, ...
Journal of Controlled Release 137 (2), 166-170, 2009
1292009
Surface chemistry and pore size affect carrier properties of mesoporous silicon microparticles
T Limnell, J Riikonen, J Salonen, AM Kaukonen, L Laitinen, J Hirvonen, ...
International journal of pharmaceutics 343 (1-2), 141-147, 2007
1282007
Determination of the physical state of drug molecules in mesoporous silicon with different surface chemistries
J Riikonen, E Mäkilä, J Salonen, VP Lehto
Langmuir 25 (11), 6137-6142, 2009
872009
Surface chemistry, reactivity, and pore structure of porous silicon oxidized by various methods
J Riikonen, M Salomaki, J van Wonderen, M Kemell, W Xu, O Korhonen, ...
Langmuir 28 (28), 10573-10583, 2012
802012
Effect of isotonic solutions and peptide adsorption on zeta potential of porous silicon nanoparticle drug delivery formulations
M Kaasalainen, E Mäkilä, J Riikonen, M Kovalainen, K Järvinen, ...
International journal of pharmaceutics 431 (1-2), 230-236, 2012
802012
Utilising thermoporometry to obtain new insights into nanostructured materials: review part 1
J Riikonen, J Salonen, VP Lehto
Journal of thermal analysis and calorimetry 105 (3), 811-821, 2011
772011
Nanostructured porous silicon microparticles enable sustained peptide (Melanotan II) delivery
M Kilpeläinen, J Mönkäre, MA Vlasova, J Riikonen, VP Lehto, J Salonen, ...
European Journal of Pharmaceutics and Biopharmaceutics 77 (1), 20-25, 2011
742011
Characterization of the Role of N-Linked Glycosylation on the Cell Signaling and Expression of the Human Thromboxane A2Receptor Alpha and BetaIsoforms
MT Walsh, JF Foley, BT Kinsella
Journal of Pharmacology and Experimental Therapeutics 286 (2), 1026-1036, 1998
66*1998
Novel delivery systems for improving the clinical use of peptides
M Kovalainen, J Mönkäre, J Riikonen, U Pesonen, M Vlasova, J Salonen, ...
Pharmacological reviews 67 (3), 541-561, 2015
642015
Improved stability and biocompatibility of nanostructured silicon drug carrier for intravenous administration
S Näkki, J Rytkönen, T Nissinen, C Florea, J Riikonen, P Ek, H Zhang, ...
Acta biomaterialia 13, 207-215, 2015
572015
Development of porous silicon nanocarriers for parenteral peptide delivery
M Kovalainen, J Monkare, M Kaasalainen, J Riikonen, VP Lehto, ...
Molecular pharmaceutics 10 (1), 353-359, 2013
552013
Intraorally fast-dissolving particles of a poorly soluble drug: Preparation and in vitro characterization
R Laitinen, E Suihko, K Toukola, M Björkqvist, J Riikonen, VP Lehto, ...
European journal of pharmaceutics and biopharmaceutics 71 (2), 271-281, 2009
532009
Amine surface modifications and fluorescent labeling of thermally stabilized mesoporous silicon nanoparticles
W Xu, J Riikonen, T Nissinen, M Suvanto, K Rilla, B Li, Q Wang, F Deng, ...
The Journal of Physical Chemistry C 116 (42), 22307-22314, 2012
462012
Mesoporous systems for poorly soluble drugs–recent trends
J Riikonen, W Xu, VP Lehto
International journal of pharmaceutics 536 (1), 178-186, 2018
392018
Systematic in vitro and in vivo study on porous silicon to improve the oral bioavailability of celecoxib
J Riikonen, A Correia, M Kovalainen, S Näkki, M Lehtonen, J Leppänen, ...
Biomaterials 52, 44-55, 2015
392015
Perphenazine solid dispersions for orally fast-disintegrating tablets: physical stability and formulation
R Laitinen, E Suihko, M Bjorkqvist, J Riikonen, VP Lehto, K Jarvinen, ...
Drug development and industrial pharmacy 36 (5), 601-613, 2010
372010
Cytotoxicity assessment of porous silicon microparticles for ocular drug delivery
E Korhonen, S Rönkkö, S Hillebrand, J Riikonen, W Xu, K Järvinen, ...
European Journal of Pharmaceutics and Biopharmaceutics 100, 1-8, 2016
342016
The system can't perform the operation now. Try again later.
Articles 1–20